{
  "main_header": {
    "sid": 1236229,
    "name": "Aquestive Therapeutics, Inc.",
    "stock_name": "Aquestive Therapeutics, Inc.",
    "full_name": "Aquestive Therapeutics, Inc.",
    "name_url": "stocks-analysis/aquestive-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "6.44",
    "chg": 0.51,
    "chgp": "8.6%",
    "dir": 1,
    "prev_price": "5.93",
    "mcapval": "606.08",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US03843E1047",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.15 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aquestive-therapeutics-inc-1236229-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Aquestive Therapeutics Stock Hits Day Low of $5.84 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aquestive-therapeutics-stock-hits-day-low-of-584-amid-price-pressure-3676145",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AquestiveTherap_priceRelatedfactors_3676145.png",
        "date": "2025-11-06 16:18:20",
        "description": "Aquestive Therapeutics, Inc. has faced notable stock volatility, declining significantly today and over the past week, despite a positive monthly performance. The company has reported negative financial results for three consecutive quarters, with a sharp drop in net sales and a concerning EBIT to interest ratio, highlighting ongoing challenges."
      },
      {
        "title": "Aquestive Therapeutics Hits New 52-Week High of $7.50, Up 165.94%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aquestive-therapeutics-hits-new-52-week-high-of-750-up-16594-3626620",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AquestiveTherap_priceRelatedfactors_3626620.png",
        "date": "2025-10-16 18:17:13",
        "description": "Aquestive Therapeutics, Inc. achieved a new 52-week high of USD 7.50 on October 15, 2025, reflecting a significant increase from its previous low. With a market capitalization of USD 606 million, the company has shown strong financial metrics despite being loss-making and having a unique debt-to-equity ratio."
      },
      {
        "title": "Aquestive Therapeutics Hits New 52-Week High of $6.97, Up 149%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aquestive-therapeutics-hits-new-52-week-high-of-697-up-149-3622783",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/AquestiveTherap_priceRelatedfactors_3622783.png",
        "date": "2025-10-15 16:55:00",
        "description": "Aquestive Therapeutics, Inc. has achieved a new 52-week high of USD 6.97, reflecting a significant increase from its previous low of USD 2.12. With a market capitalization of USD 606 million, the company has shown strong financial metrics despite being loss-making and having a negative debt-to-equity ratio."
      },
      {
        "title": "Aquestive Therapeutics Hits New 52-Week High of $6.43",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aquestive-therapeutics-hits-new-52-week-high-of-643-3579355",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/AquestiveTherap_priceRelatedfactors_3579355.png",
        "date": "2025-09-29 14:20:49",
        "description": "Aquestive Therapeutics, Inc. has achieved a new 52-week high, reflecting a significant increase from its previous low and showcasing a strong one-year performance compared to the S&P 500. With a market capitalization of USD 606 million, the company exhibits impressive financial metrics despite currently being loss-making."
      },
      {
        "title": "Aquestive Therapeutics Hits New 52-Week High of $6.00, Up 105.43%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aquestive-therapeutics-hits-new-52-week-high-of-600-up-10543-3552553",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/AquestiveTherap_priceRelatedfactors_3552553.png",
        "date": "2025-09-22 18:13:10",
        "description": "Aquestive Therapeutics, Inc. has achieved a new 52-week high, reflecting a significant increase from its previous low and showcasing a strong one-year performance. With a market capitalization of USD 606 million, the company demonstrates effective equity management despite being loss-making and facing challenges in asset valuation."
      },
      {
        "title": "Is Aquestive Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-aquestive-therapeutics-inc-technically-bullish-or-bearish-3547192",
        "imagepath": "",
        "date": "2025-09-20 19:49:14",
        "description": "As of 4 September 2025, the technical trend for Aquestive Therapeutics, Inc. has changed from mildly bullish to bullish. The current stance is bullish with a strong indication from the moving averages, which are bullish on the daily timeframe. The MACD is also bullish on both the weekly and monthly timeframes. However, the weekly RSI is bearish, indicating some short-term weakness. \n\nOverall, the stock has shown a strong performance year-to-date with a return of 38.76%, significantly outperforming the S&P 500's 12.22% during the same period...."
      }
    ],
    "total": 10,
    "sid": "1236229",
    "stock_news_url": "https://www.marketsmojo.com/news/aquestive-therapeutics-inc-1236229"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Aquestive Therapeutics Stock Hits Day Low of $5.84 Amid Price Pressure

2025-11-06 16:18:20

Aquestive Therapeutics, Inc. has faced notable stock volatility, declining significantly today and over the past week, despite a positive monthly performance. The company has reported negative financial results for three consecutive quarters, with a sharp drop in net sales and a concerning EBIT to interest ratio, highlighting ongoing challenges.

Read More

Aquestive Therapeutics Hits New 52-Week High of $7.50, Up 165.94%

2025-10-16 18:17:13

Aquestive Therapeutics, Inc. achieved a new 52-week high of USD 7.50 on October 15, 2025, reflecting a significant increase from its previous low. With a market capitalization of USD 606 million, the company has shown strong financial metrics despite being loss-making and having a unique debt-to-equity ratio.

Read More

Aquestive Therapeutics Hits New 52-Week High of $6.97, Up 149%

2025-10-15 16:55:00

Aquestive Therapeutics, Inc. has achieved a new 52-week high of USD 6.97, reflecting a significant increase from its previous low of USD 2.12. With a market capitalization of USD 606 million, the company has shown strong financial metrics despite being loss-making and having a negative debt-to-equity ratio.

Read More

Aquestive Therapeutics Hits New 52-Week High of $6.43

2025-09-29 14:20:49

Aquestive Therapeutics, Inc. has achieved a new 52-week high, reflecting a significant increase from its previous low and showcasing a strong one-year performance compared to the S&P 500. With a market capitalization of USD 606 million, the company exhibits impressive financial metrics despite currently being loss-making.

Read More

Aquestive Therapeutics Hits New 52-Week High of $6.00, Up 105.43%

2025-09-22 18:13:10

Aquestive Therapeutics, Inc. has achieved a new 52-week high, reflecting a significant increase from its previous low and showcasing a strong one-year performance. With a market capitalization of USD 606 million, the company demonstrates effective equity management despite being loss-making and facing challenges in asset valuation.

Read More

Is Aquestive Therapeutics, Inc. technically bullish or bearish?

2025-09-20 19:49:14

As of 4 September 2025, the technical trend for Aquestive Therapeutics, Inc. has changed from mildly bullish to bullish. The current stance is bullish with a strong indication from the moving averages, which are bullish on the daily timeframe. The MACD is also bullish on both the weekly and monthly timeframes. However, the weekly RSI is bearish, indicating some short-term weakness. Overall, the stock has shown a strong performance year-to-date with a return of 38.76%, significantly outperforming the S&P 500's 12.22% during the same period....

Read More

View All News